Everthing in announcement seems okay expect the fact the trial...

Everthing in announcement seems okay expect the fact the trial has not progressed that far. credibility will become an issue with investors if the company keeps falling well short in their trial completion. Was suppossed to be finished in July. then december. Now we have found out today they have only completed 300 more tests since august. Results good just credibility of company being questioned i would say.

Moving back up a little now which is a good sign. Was hoping that trial would be completed and share would be on way to $2.

Oh well just proves that you cant believe everything you hear.